Orphan Drug - Global Market Outlook (2016-2022)                     

Orphan Drug - Global Market Outlook (2016-2022)                     

  • Published: March 2017
  • ID: SMRC16404

According to Stratistics MRC, the Global Orphan Drug market is estimated at $145.89 million in 2016 and is expected to reach $265.63 million by 2022 growing at a CAGR of 10.5% from 2016 to 2022. Rising focus of big pharmaceutical companies on orphan drug improvement, increasing occurrence of rare diseases, government incentives for orphan medicine are some factors favouring the market growth. However, some factors such as high initial investment that leads to higher per patient treatment cost, reimbursement uncertainties and high cost of drug development are hindering the market. North America registered significant growth for the market during the forecast period due to rising healthcare spending, constructive government initiatives, growing occurrence of chronic diseases and small timeline required for orphan drug development.

Some of the key players in the market include Abbott Laboratories, AbbVie Inc., Alexion Pharmaceuticals, Amgen, Inc., Bayer Healthcare, Boehringer Ingelheim GmbH, Bristol Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche AG, Genentech, Janssen Biotech, Inc.,
Johnson & Johnson, Merck & Co., Inc., Novartis, Pfizer Inc., Roche Holding AG, Sanofi Aventis and Vertex Pharmaceuticals.

Drug Types Covered:
• Biological orphan drugs
• Non-biological orphan drugs

Applications Covered:
• Blood-related disorders
• Nephrology
• Neurology
• Oncology
• Infectious diseases
• Cystic fibrosis
• Other Applications

Technologies Covered:
• DNA recombination
• Hybridoma and gene mapping
• Transgenic
• Other Technologies

Pharmacological classes Covered:
• Enzyme replacement
• Gene and chromosome expression
• Protein replacement

Indications Covered:
• Acute Myeloid Leukemia
• Duchenne Muscular Dystrophy
• Glioma
• Graft vs Host Disease
• Multiple Myeloma
• Non-Hodgkin Lymphoma
• Ovarian Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Other Indications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain  
o Rest of Europe    
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific    
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Select License Type

Single User License (PDF)


2 - 5 User License (PDF)


Corporate License (PDF)


Have a Question?

Know our Methodology


Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.